|
Clinical characteristics, use of medication and fasting lipid variables in the no dietary advice and the dietary advice groups, and in the placebo (corn oil) and the n-3 PUFA supplemented groups. Median values (25, 75 percentiles) or proportions are given. |
||||
| No Diet Intervention |
Diet Intervention |
Placebo (corn oil) |
n-3 PUFA |
|
|
|
||||
| n |
279 |
279 |
281 |
282 |
| Age (yrs)(range) |
70 (67, 76) |
70 (67, 73) |
70 (67, 72) |
70 (68, 73) |
| Verified CVD % |
28 |
28 |
27 |
28 |
| Diabetes % |
16 |
14 |
17 |
13 |
| Hypertension % |
32 |
29 |
29 |
32 |
| Smokers % |
33 |
35 |
33 |
35 |
| Medications: % |
||||
| Statins |
25 |
29 |
25 |
29 |
| Acetylsalicylic acid |
27 |
25 |
28 |
25 |
| βeta-blockers |
19 |
14 |
16 |
17 |
| ACE-inhibitors |
17 |
13 |
15 |
15 |
| Nitrates |
11 |
7 |
7 |
10 |
| Total Cholesterol (mmol/L) |
6.4 (5.8, 7.0) |
6.3 (5.5, 6.9) |
6.3 (5.6, 6.8) |
6.3 (5.7, 7.1) |
| HDL-C (mmol/L) |
1.4 (1.1, 1.6) |
1.4 (1.2, 1.6) |
1.4 (1.2, 1.6) |
1.4 (1.2, 1.6) |
| LDL-C (mmol/L) |
4.1 (3.5, 4.8) |
4.0 (3.5, 4.6) |
4.1 (3.5, 4.6) |
4.1 (3.5, 4.8) |
| Triglycerides (mmol/L) |
1.5 (1.3, 2.1) |
1.6 (1.1, 2.0) |
1.5 (1.1, 2.0) |
1.6 (1.1, 2.1) |
|
CVD: Cardiovascular disease, ACE: Angiotensin converting enzyme, HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein cholesterol | ||||
Eid et al. Nutrition & Metabolism 2006 3:4 doi:10.1186/1743-7075-3-4 |
||||